D.E. Shaw & Co
DMIIR

D.E. Shaw & Co’s Drugs Made In America Acquisition II Corp Right DMIIR Stock Holding History

D.E. Shaw & Co’s Portfolio DMIIR Stock Details DMIIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$80K Hold
1,000,000
– – ﹤0.01% 4306
2025
Q4 		$140K Buy
+1,000,000
New +$143K ﹤0.01% 4375

Other funds holding DMIIR

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return

D.E. Shaw & Co's DMIIR Position: Q1 2026 in Review

D.E. Shaw & Co held its Drugs Made In America Acquisition II Corp Right (DMIIR) position steady in Q1 2026 at 1,000,000 shares worth $80K. The position accounts for ﹤0.01% of the portfolio, ranked #4306.

D.E. Shaw & Co first reported a position in DMIIR in Q4 2025 and has held it in 2 quarters since. The position peaked at $140K in Q4 2025. 57 funds tracked by Wall St. Rank hold DMIIR as of Q1 2026.

  • D.E. Shaw & Co held 1,000,000 shares of Drugs Made In America Acquisition II Corp Right worth $80K as of Q1 2026.
  • D.E. Shaw & Co left its Drugs Made In America Acquisition II Corp Right share count unchanged in Q1 2026.
  • Drugs Made In America Acquisition II Corp Right made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #4306 holding.
  • D.E. Shaw & Co first reported a position in Drugs Made In America Acquisition II Corp Right in Q4 2025 and has held it in 2 quarters since.
  • D.E. Shaw & Co's Drugs Made In America Acquisition II Corp Right position peaked at $140K in Q4 2025.
  • 57 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Right as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.